Aeterna Zentaris
AEZS
#10196
Rank
โ‚น1.60 B
Marketcap
โ‚น524.19
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): -โ‚น170.14

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -โ‚น187.76. In 2022 the company made an earnings per share (EPS) of -โ‚น428.88 a decrease over its 2021 EPS that were of -โ‚น166.79.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น170.14
2022-โ‚น428.88157.14%
2021-โ‚น166.79-41.48%
2020-โ‚น285.00-64.46%
2019-โ‚น801.86-240%
2018โ‚น572.76-122.32%
2017-โ‚น2,566-53.53%
2016-โ‚น5,521-86.71%
2015-โ‚น41,559-35.21%
2014-โ‚น64,149-216.67%
2013โ‚น54,985-123.3%
2012-โ‚น2,35,976-40.8%
2011-โ‚น3,98,638-6.45%
2010-โ‚น4,26,130-27.91%
2009-โ‚น5,91,083-61.61%
2008-โ‚น15,39,56683.61%
2007-โ‚น8,38,513-195.31%
2006โ‚น8,79,752178.26%
2005โ‚น3,16,161-330%
2004-โ‚น1,37,461-80.05%
2003-โ‚น6,89,01817.78%
2002-โ‚น5,85,012515.93%
2001-โ‚น94,981-68.6%
2000-โ‚น3,02,516119.62%
1999-โ‚น1,37,743-3.63%
1998-โ‚น1,42,938

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น674.48-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น339.59-280.86%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น272.17-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น32.99-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚น448.12-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA